Macrophage migration inhibitory factor evaluation compared with prostate specific antigen as a biomarker in patients with prostate carcinoma.
about
Inhibition of macrophage migration inhibitory factor decreases proliferation and cytokine expression in bladder cancer cellsAnatomical location of macrophage migration inhibitory factor in urogenital tissues, peripheral ganglia and lumbosacral spinal cord of the ratFurther evidence for increased macrophage migration inhibitory factor expression in prostate cancer.Macrophage migration inhibitory factor-CXCR4 is the dominant chemotactic axis in human mesenchymal stem cell recruitment to tumors.Identification of macrophage migration inhibitory factor and human neutrophil peptides 1-3 as potential biomarkers for gastric cancerMacrophage migration inhibitory factor anti-thrombin III complexes are decreased in bladder cancer patient serum: Complex formation as a mechanism of inactivationTrichomonas vaginalis homolog of macrophage migration inhibitory factor induces prostate cell growth, invasiveness, and inflammatory responsesβ-Arrestin1 mediates the endocytosis and functions of macrophage migration inhibitory factorAssociation between macrophage migration inhibitory factor promoter region polymorphism (-173 G/C) and cancer: a meta-analysisMacrophage migration inhibitory factor is secreted by rhabdomyosarcoma cells, modulates tumor metastasis by binding to CXCR4 and CXCR7 receptors and inhibits recruitment of cancer-associated fibroblastsMacrophage Migration Inhibitory Factor Secretion Is Induced by Ionizing Radiation and Oxidative Stress in Cancer Cells.Steroid receptor coactivator 3 regulates autophagy in breast cancer cells through macrophage migration inhibitory factorQuantitative analysis of macrophage inhibitory cytokine-1 (MIC-1) gene expression in human prostatic tissuesMacrophage migration inhibitory factor contributes to the immune escape of ovarian cancer by down-regulating NKG2D.Role of MIF/CD74 signaling pathway in the development of pleural mesotheliomaMechanisms of macrophage migration inhibitory factor (MIF)-dependent tumor microenvironmental adaptation.The role of macrophage inhibitory factor in tumorigenesis and central nervous system tumors.Plasma Levels of Macrophage Migration Inhibitory Factor and d-Dopachrome Tautomerase Show a Highly Specific Profile in Early Life.CD74: a new prognostic factor for patients with malignant pleural mesothelioma.Macrophage migration inhibitory factor (MIF): a promising biomarker.Targeting MIF in Cancer: Therapeutic Strategies, Current Developments, and Future Opportunities.Functional disruption of macrophage migration inhibitory factor (MIF) suppresses proliferation of human H460 lung cancer cells by caspase-dependent apoptosis.Luminescent Strategies for Label-free G-quadruplex-based Enzyme Activity Sensing.Macrophage migration inhibitory factor (MIF) is induced by cytotoxic drugs and is involved in immune escape and migration in childhood rhabdomyosarcoma.Loss of macrophage migration inhibitory factor impairs the growth properties of human HeLa cervical cancer cells.Protein biomarker quantification by mass spectrometry.Regulation of human lung adenocarcinoma cell migration and invasion by macrophage migration inhibitory factor.Macrophage migration inhibitory factor stimulated by Helicobacter pylori increases proliferation of gastric epithelial cells.Serum and salivary macrophage migration inhibitory factor in patients with oral squamous cell carcinoma.Elevated expression of macrophage migration inhibitory factor correlates with tumor recurrence and poor prognosis of patients with gliomas.Macrophage migration inhibitory factor contributes angiogenesis by up-regulating IL-8 and correlates with poor prognosis of patients with primary nasopharyngeal carcinoma.Tumor-derived macrophage migration inhibitory factor promotes an autocrine loop that enhances renal cell carcinoma.
P2860
Q24793870-BEC670A4-2246-409D-8F47-09C82F365D57Q24795479-A59F56FA-01A8-4412-9925-395DB323156CQ24813097-BADBCCAD-E1BE-4C72-BF34-FA0FBEDA77EBQ30632123-EC2394E6-E7EC-4E29-964C-2558A12B8CC4Q33473141-C28EE6EE-42BB-4C2D-BB9F-F851309A3DF1Q33703397-663C2B77-8DFE-4EB5-97CF-CDCA33215FB7Q33730715-1FCAC05B-73D3-457E-94A2-2AE2D9318F9BQ33808587-DCC0495F-90F9-4F5E-ACAB-BAD3F11ABF18Q34100932-E462AE36-A5C7-48F5-9A20-89FBC6622E02Q34280104-94F772C4-D332-4A03-9944-AB72FE182AE0Q35888073-E4ED3139-706B-4539-BDBC-6CCF4CF31B7AQ36009215-00105B44-9146-4E9F-9D76-66E4772B0ECEQ36646676-C17FD6A1-211C-4800-AEF3-F0E2AB4BCDA4Q36715028-02037D11-246D-4B62-B598-1E22B59E895AQ36998296-9635E991-DE7B-4540-B7C2-09D355796C53Q37187775-D640E8B6-4C31-4503-A2B4-A84587FC8DD0Q37424971-1AFBE1C1-F3BC-4762-B38B-087B6C439CF2Q37604131-05E18C0D-3C86-4811-B081-967987D6AB82Q37711647-E887F7CA-7088-4A42-945A-31C3F2C2F08AQ37762450-49593838-D885-47F0-B7B8-F278F9B95485Q38700157-4169FFFF-2697-45F6-99C7-01036958FA69Q39177042-ECA9C406-90A2-4D0D-940F-6C058E03A264Q39280626-144E993D-58C5-4BE3-826D-9E1A62C2B7C5Q39389184-4E674760-E80D-447E-A3A5-ED0CCE024D51Q39459454-34798B74-9A88-44AA-8F43-0788BCB87412Q39913983-7C41CBBB-C97F-44F7-8C09-E6A1D58139FCQ40091422-C91B1796-CFC0-4862-825B-40D847AB9827Q40440746-7344618D-64A9-4FBA-BA91-56BC6EC0DA6FQ42930936-DF4AAB0B-E3B1-496E-AA0D-322C82829D20Q44525447-0D098051-4F66-4676-9188-440AFCFD5E2EQ46003105-756EF9B2-5DFC-46B3-9C62-ACCE55CDB45CQ54514280-0F1FAA31-530E-4D1D-B967-6DDDC8695F8A
P2860
Macrophage migration inhibitory factor evaluation compared with prostate specific antigen as a biomarker in patients with prostate carcinoma.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մարտին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Macrophage migration inhibitor ...... ients with prostate carcinoma.
@ast
Macrophage migration inhibitor ...... ients with prostate carcinoma.
@en
type
label
Macrophage migration inhibitor ...... ients with prostate carcinoma.
@ast
Macrophage migration inhibitor ...... ients with prostate carcinoma.
@en
prefLabel
Macrophage migration inhibitor ...... ients with prostate carcinoma.
@ast
Macrophage migration inhibitor ...... ients with prostate carcinoma.
@en
P2093
P2860
P356
P1433
P1476
Macrophage migration inhibitor ...... ients with prostate carcinoma.
@en
P2093
Katherine L Meyer-Siegler
Michael A Bellino
Myron Tannenbaum
P2860
P304
P356
10.1002/CNCR.10354
P407
P577
2002-03-01T00:00:00Z